Dent RA - Search Results

1

Evaluation of phospho-histone H3 in Asian triple-negative breast cancer using multiplex immunofluorescence.

Lai CPT, Yeong JPS, Tan AS, Ong CHC, Lee B, Lim JCT, Thike AA, Iqbal J, Dent RA, Lim EH, Tan PH. Lai CPT, et al. Among authors: dent ra. Breast Cancer Res Treat. 2019 Nov;178(2):295-305. doi: 10.1007/s10549-019-05396-5. Epub 2019 Aug 13. Breast Cancer Res Treat. 2019. PMID: 31410680

2

Pattern of metastatic spread in triple-negative breast cancer.

Dent R, Hanna WM, Trudeau M, Rawlinson E, Sun P, Narod SA. Dent R, et al. Breast Cancer Res Treat. 2009 May;115(2):423-8. doi: 10.1007/s10549-008-0086-2. Epub 2008 Jun 10. Breast Cancer Res Treat. 2009. PMID: 18543098

3

Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers.

Nofech-Mozes S, Trudeau M, Kahn HK, Dent R, Rawlinson E, Sun P, Narod SA, Hanna WM. Nofech-Mozes S, et al. Breast Cancer Res Treat. 2009 Nov;118(1):131-7. doi: 10.1007/s10549-008-0295-8. Epub 2009 Feb 3. Breast Cancer Res Treat. 2009. PMID: 19189211

4

Platinum-based chemotherapy in triple-negative advanced breast cancer.

Villarreal-Garza C, Khalaf D, Bouganim N, Clemons M, Peña-Curiel O, Baez-Revueltas B, Kiss A, Kassam F, Enright K, Verma S, Pritchard K, Myers J, Dent R. Villarreal-Garza C, et al. Breast Cancer Res Treat. 2014 Aug;146(3):567-72. doi: 10.1007/s10549-014-3033-4. Epub 2014 Jul 8. Breast Cancer Res Treat. 2014. PMID: 25001611

5

Role of inflammatory infiltrates in triple negative breast cancer.

Matsumoto H, Koo SL, Dent R, Tan PH, Iqbal J. Matsumoto H, et al. J Clin Pathol. 2015 Jul;68(7):506-10. doi: 10.1136/jclinpath-2015-202944. Epub 2015 Mar 6. J Clin Pathol. 2015. PMID: 25750267 Review.

6

Prognostic role of adjuvant radiotherapy in triple-negative breast cancer: A historical cohort study.

Bhoo-Pathy N, Verkooijen HM, Wong FY, Pignol JP, Kwong A, Tan EY, Aishah Taib N, Nei WL, Ho GF, Tan B, Chan P, Lee SC, Hartman M, Yip CH, Dent R. Bhoo-Pathy N, et al. Int J Cancer. 2015 Nov 15;137(10):2504-12. doi: 10.1002/ijc.29617. Epub 2015 Jul 14. Int J Cancer. 2015. PMID: 26018878 Free article.

7

Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.

Matsumoto H, Thike AA, Li H, Yeong J, Koo SL, Dent RA, Tan PH, Iqbal J. Matsumoto H, et al. Among authors: dent ra. Breast Cancer Res Treat. 2016 Apr;156(2):237-47. doi: 10.1007/s10549-016-3743-x. Epub 2016 Mar 9. Breast Cancer Res Treat. 2016. PMID: 26960711

8

Ten-year survival in women with primary stage IV breast cancer.

Eng LG, Dawood S, Sopik V, Haaland B, Tan PS, Bhoo-Pathy N, Warner E, Iqbal J, Narod SA, Dent R. Eng LG, et al. Breast Cancer Res Treat. 2016 Nov;160(1):145-152. doi: 10.1007/s10549-016-3974-x. Epub 2016 Sep 14. Breast Cancer Res Treat. 2016. PMID: 27628191

9

Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.

Chae JW, Chua PS, Ng T, Yeo AHL, Shwe M, Gan YX, Dorajoo S, Foo KM, Loh KW, Koo SL, Chay WY, Tan TJY, Beh SY, Lim EH, Lee GE, Dent R, Yap YS, Ng R, Ho HK, Chan A. Chae JW, et al. Breast Cancer Res Treat. 2018 Apr;168(3):713-721. doi: 10.1007/s10549-017-4640-7. Epub 2018 Jan 8. Breast Cancer Res Treat. 2018. PMID: 29313215

10

Are There Any Clinically Relevant Subgroups of Triple-Negative Breast Cancer in 2018?

Chan JJ, Tan TJY, Dent RA. Chan JJ, et al. Among authors: dent ra. J Oncol Pract. 2018 May;14(5):281-289. doi: 10.1200/JOP.18.00034. J Oncol Pract. 2018. PMID: 29746805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page